{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T15:37:33Z","timestamp":1770997053551,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2000,3,1]],"date-time":"2000-03-01T00:00:00Z","timestamp":951868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2000,3]]},"DOI":"10.1016\/s0002-9149(99)00826-7","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T13:52:56Z","timestamp":1027605176000},"page":"645-650","source":"Crossref","is-referenced-by-count":42,"title":["Raising low levels of high-density lipoprotein cholesterol is an important target of therapy"],"prefix":"10.1016","volume":"85","author":[{"given":"William E","family":"Boden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas A","family":"Pearson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0002-9149(99)00826-7_BIB1","first-page":"1383","article-title":"Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/S0002-9149(99)00826-7_BIB2","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels","volume":"335","author":"Sacks","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-9149(99)00826-7_BIB3","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","article-title":"Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels","volume":"339","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-9149(99)00826-7_BIB4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1056\/NEJM199701163360301","article-title":"The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts","volume":"336","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-9149(99)00826-7_BIB5","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia","volume":"333","author":"Shepherd","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-9149(99)00826-7_BIB6","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1001\/jama.279.20.1615","article-title":"Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. Results of AFCAPS\/TexCAPS","volume":"279","author":"Downs","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/S0002-9149(99)00826-7_BIB7","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1126\/science.111.2877.166","article-title":"The role of lipids and lipoproteins in atherosclerosis","volume":"111","author":"Gofman","year":"1950","journal-title":"Science"},{"key":"10.1016\/S0002-9149(99)00826-7_BIB8","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1001\/jama.1993.03500230097036","article-title":"National Cholesterol Education Program. Summary of the Second Report of the Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)","volume":"269","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/S0002-9149(99)00826-7_BIB9","doi-asserted-by":"crossref","first-page":"515","DOI":"10.7326\/0003-4819-124-5-199603010-00012","article-title":"Guidelines for coronary serum cholesterol, high-density lipoprotein cholesterol, and triglyceride levels on screening tests for prevention of coronary heart disease in adults","volume":"124","year":"1996","journal-title":"Ann Intern Med"},{"issue":"suppl 5","key":"10.1016\/S0002-9149(99)00826-7_BIB10","first-page":"53","article-title":"Prevention of coronary heart disease in clinical practice","volume":"1","year":"1999","journal-title":"Eur Heart J"},{"key":"10.1016\/S0002-9149(99)00826-7_BIB11","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0002-9343(77)90874-9","article-title":"High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study","volume":"62","author":"Gordon","year":"1977","journal-title":"Am J Med"},{"key":"10.1016\/S0002-9149(99)00826-7_BIB12","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1001\/jama.1986.03380200073024","article-title":"Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study","volume":"256","author":"Castelli","year":"1986","journal-title":"JAMA"},{"key":"10.1016\/S0002-9149(99)00826-7_BIB13","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/S0002-9149(99)80761-9","article-title":"Distribution of lipids in 8,500 men with coronary artery disease","volume":"75","author":"Rubins","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/S0002-9149(99)00826-7_BIB14","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/0735-1097(92)90520-W","article-title":"Lipoprotein cholesterol, apolipoprotein A-1 and B and lipoprotein (a) abnormalities in men with premature coronary artery disease","volume":"19","author":"Genest","year":"1992","journal-title":"J Am Coll Cardiol"},{"issue":"suppl","key":"10.1016\/S0002-9149(99)00826-7_BIB15","first-page":"5A","article-title":"Cholesterol and lipids in the risk of coronary artery disease\u2014the Framingham Heart Study","volume":"4","author":"Castelli","year":"1988","journal-title":"Can J Cardiol"},{"key":"10.1016\/S0002-9149(99)00826-7_BIB16","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/oxfordjournals.aje.a112682","article-title":"The association of low levels of HDL cholesterol and arteriographically defined coronary artery disease","volume":"109","author":"Pearson","year":"1979","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S0002-9149(99)00826-7_BIB17","first-page":"1165","volume":"86","author":"Miller","year":"1992","journal-title":"Longterm predictors of subsequent cardiovascular events with coronary artery disease and \u201cdesirable\u201d levels of plasma total cholesterol Circulation"},{"key":"10.1016\/S0002-9149(99)00826-7_BIB18","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1161\/01.CIR.85.1.37","article-title":"Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentration on coronary heart disease risk in the Helsinki Heart Study","volume":"85","author":"Manninen","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/S0002-9149(99)00826-7_BIB19","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0009-9120(97)00098-2","article-title":"Reverse cholesterol transport 190 a review of the process and its clinical implications","volume":"30","author":"Hill","year":"1997","journal-title":"Clin Biochem"},{"key":"10.1016\/S0002-9149(99)00826-7_BIB20","first-page":"721","article-title":"HDL apolipoprotein A-I attenuates oxidative modification of low-density lipoprotein","author":"Hayek","year":"1995","journal-title":"Eur J Clin Chem Clin Biochem"},{"key":"10.1016\/S0002-9149(99)00826-7_BIB21","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0014-5793(91)80962-3","article-title":"Paraoxonase prevents accumulation of lipoperoxides in low-density lipoproteins","volume":"286","author":"Mackness","year":"1991","journal-title":"FEBS Lett"},{"key":"10.1016\/S0002-9149(99)00826-7_BIB22","unstructured":"Rubins HB. Current status of HDL intervention trials. Paper presented at: High-Density Lipoproteins and Coronary Heart Disease: A Symposium; November 7, 1998. Dallas, TX."},{"key":"10.1016\/S0002-9149(99)00826-7_BIB23","unstructured":"Rubins HB. Late-breaking clinical trials: Plenary session XII. Paper presented at: 71st Scientific Sessions of the American Heart Association; November 8-12, 1998; Dallas, TX."},{"key":"10.1016\/S0002-9149(99)00826-7_BIB24","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1056\/NEJM199908053410604","article-title":"Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol","volume":"341","author":"Rubins","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-9149(99)00826-7_BIB25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1172\/JCI116541","article-title":"Insulin resistance and hyperinsulinemia in individuals with small, dense low-density lipoprotein particles","volume":"92","author":"Reaven","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/S0002-9149(99)00826-7_BIB26","first-page":"36","article-title":"The atherogenic lipoprotein profile","volume":"4","author":"Superko","year":"1997","journal-title":"Sci Med"},{"key":"10.1016\/S0002-9149(99)00826-7_BIB27","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0146-2806(96)80005-3","article-title":"Lipid disorders contributing to coronary heart disease","volume":"21","author":"Superko","year":"1996","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/S0002-9149(99)00826-7_BIB28","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/S0002-9149(99)00153-8","article-title":"Effects of higher doses of simvastatin, and atorvastatin on high-density lipoprotein cholesterol, and apolipoprotein","author":"Crouse","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/S0002-9149(99)00826-7_BIB29","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2796.1989.tb01393.x","article-title":"Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acid","volume":"226","author":"Carlson","year":"1989","journal-title":"J Intern Med"},{"key":"10.1016\/S0002-9149(99)00826-7_BIB30","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0021-9150(92)90177-I","article-title":"Differential effects of nicotinic acid in subjects with different LDL subclass patterns","volume":"95","author":"Superko","year":"1992","journal-title":"Atherosclerosis"},{"key":"10.1016\/S0002-9149(99)00826-7_BIB31","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00043798-199706000-00002","article-title":"Nicotinic acid treatment shifts the fibrinolytic balance favourably and decreases plasma fibrinogen in hypertriglyceridemic men","volume":"4","author":"Johansson","year":"1997","journal-title":"J Cardiovasc Risk"},{"key":"10.1016\/S0002-9149(99)00826-7_BIB32","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/107424849600100302","article-title":"Treatment effect of niaspan, a controlled-release niacin, in patients with hypercholesterolemia","volume":"1","author":"Morgan","year":"1996","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/S0002-9149(99)00826-7_BIB33","unstructured":"Guyton JR. A comparative study of the effects of extended-release niacin and gemfibrozil on HDL levels in patients with low HDL cholesterol. Paper presented at: High-Density Lipoproteins and Coronary Heart Disease: A Symposium; November 7, 1988; Dallas, TX."},{"key":"10.1016\/S0002-9149(99)00826-7_BIB34","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1056\/NEJM199907083410202","article-title":"Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-9149(99)00826-7_BIB35","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1161\/01.CIR.85.4.1279","article-title":"Low high-density lipoprotein level is associated with increased restenosis rate after coronary angioplasty","volume":"85","author":"Shah","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/S0002-9149(99)00826-7_BIB36","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0002-9149(99)80691-2","article-title":"Effect of serum lipid concentration on restenosis after successful de novo percutaneous transluminal coronary angioplasty in patients with total cholesterol 160 to 240 mg\/dl and triglycerides <350 mg\/dl","volume":"75","author":"Dzavik","year":"1995","journal-title":"Am J Cardiol"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914999008267?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914999008267?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T18:01:43Z","timestamp":1620324103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914999008267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2000,3]]}},"alternative-id":["S0002914999008267"],"URL":"https:\/\/doi.org\/10.1016\/s0002-9149(99)00826-7","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2000,3]]}}}